Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shima

Showing results (351-360 of 376) with videos related to

Pageof 38
Sort By:
Epidemiology and Infection|February 24, 2015
Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012T Ikebe, K Tominaga, T Shima, et al.
The American Journal of Pathology|September 1, 1994
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate modelJ W Miller, A P Adamis, D T Shima, et al.
Investigative Ophthalmology & Visual Science|May 22, 2014
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunctionNorihiro Nagai, Pete Lundh von Leithner, Kanako Izumi-Nagai, et al.
Radiation Protection Dosimetry|December 26, 2013
Measurements of the neutron activation cross sections for Bi and Co at 386 MeVH Yashima, S Sekimoto, K Ninomiya, et al.
Epidemiology and Infection|July 31, 2010
Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slumD Sur, B Manna, S K Niyogi, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Developmental Cell|September 2, 2014
Differential apicobasal VEGF signaling at vascular blood-neural barriersNatalie Hudson, Michael B Powner, Mosharraf H Sarker, et al.
Developmental Biology|June 23, 2020
Macrophages fine-tune pupil shape during developmentMoe Takahashi, Mika Misaki, Shinsuke Shibata, et al.
The Journal of Experimental Medicine|August 6, 2003
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularizationSusumu Ishida, Tomohiko Usui, Kenji Yamashiro, et al.
Pageof 38

Showing results (351-360 of 376) with videos related to

Sort By:
Pageof 38
Epidemiology and Infection|February 24, 2015
Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012T Ikebe, K Tominaga, T Shima, et al.
The American Journal of Pathology|September 1, 1994
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate modelJ W Miller, A P Adamis, D T Shima, et al.
Investigative Ophthalmology & Visual Science|May 22, 2014
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunctionNorihiro Nagai, Pete Lundh von Leithner, Kanako Izumi-Nagai, et al.
Radiation Protection Dosimetry|December 26, 2013
Measurements of the neutron activation cross sections for Bi and Co at 386 MeVH Yashima, S Sekimoto, K Ninomiya, et al.
Epidemiology and Infection|July 31, 2010
Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slumD Sur, B Manna, S K Niyogi, et al.
The American Journal of Pathology|July 19, 2015
Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular PermeabilityNori Nagai, Meihua Ju, Kanako Izumi-Nagai, et al.
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Developmental Cell|September 2, 2014
Differential apicobasal VEGF signaling at vascular blood-neural barriersNatalie Hudson, Michael B Powner, Mosharraf H Sarker, et al.
Developmental Biology|June 23, 2020
Macrophages fine-tune pupil shape during developmentMoe Takahashi, Mika Misaki, Shinsuke Shibata, et al.
The Journal of Experimental Medicine|August 6, 2003
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularizationSusumu Ishida, Tomohiko Usui, Kenji Yamashiro, et al.
Pageof 38